1. FDA decision coming soon on Aimmune's contested peanut allergy drug — Roche's Tecentriq fails in bladder cancer trial — Pfizer launches biosims for Roche's 'big three' cancer drugs in the US — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Expansion Questions

Discussion in 'Promius Pharma' started by Anonymous, Sep 26, 2012 at 11:28 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What is the new product that you are expecting approval of this year?

    I know you promote Cloderm and Promiseb but do you still promote Epiceram too?

    What is the company like?
    Any information is greatly appreciated as I am interviewing for one of the new territories.
     

  2. Anonymous

    Anonymous Guest

    Who did you interview with?
     
  3. Anonymous

    Anonymous Guest

    The new product is a branded generic accutane called Zenatane. It will compete with Claravis, Absorica, Myorisan, Amnesteem and Sotret.
     
  4. Anonymous

    Anonymous Guest

    I thought Promius was buying Aqua?
     
  5. Anonymous

    Anonymous Guest

    How does this company still exist? What's the bonus payout averages?
     
  6. Anonymous

    Anonymous Guest

    Is this product approved?
     
  7. Anonymous

    Anonymous Guest

    How many managers and reps are in your sales force?